These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30213713)

  • 41. Prospective nonrandomized study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy to magnetic resonance imaging with subsequent MRI-guided biopsy in biopsy-naïve patients.
    Castellucci R; Linares Quevedo AI; Sánchez Gómez FJ; Díez Rodríguez J; Cogorno L; Cogollos Acuña I; Salmerón Béliz I; Muñoz Fernández de Legaría M; Martínez Piñeiro L
    Minerva Urol Nefrol; 2017 Dec; 69(6):589-595. PubMed ID: 29094851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
    Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
    J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic accuracy of multiparametric magnetic resonance imaging in detecting extracapsular extension in intermediate and high - risk prostate cancer.
    Dominguez C; Plata M; Cataño JG; Palau M; Aguirre D; Narvaez J; Trujillo S; Gómez F; Trujillo CG; Caicedo JI; Medina C
    Int Braz J Urol; 2018; 44(4):688-696. PubMed ID: 29570254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequency of Unnecessarily Biopsies among Patients with Suspicion of Prostate Cancer in Syrian Men.
    Bachour DM; Chahin E; Al-Fahoum S
    Asian Pac J Cancer Prev; 2015; 16(14):5967-70. PubMed ID: 26320481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current practice and access to prostate MR imaging in France.
    Renard-Penna R; Rouvière O; Puech P; Borgogno C; Abbas L; Roy C; Claudon M; Correas JM; Cormier L; Ploussard G; Mejean A; Tezenas-du-Montcel S; Rozet F
    Diagn Interv Imaging; 2016 Nov; 97(11):1125-1129. PubMed ID: 27451262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy.
    Miyamoto S; Ito K; Miyakubo M; Suzuki R; Yamamoto T; Suzuki K; Suzuki K; Yamanaka H
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):75-86. PubMed ID: 21986985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Direct MRI-Guided Biopsy of the Prostate on Clinical Management.
    Meermeier NP; Foster BR; Liu JJ; Amling CL; Coakley FV
    AJR Am J Roentgenol; 2019 Aug; 213(2):371-376. PubMed ID: 30933652
    [No Abstract]   [Full Text] [Related]  

  • 50. Repeat transrectal ultrasound biopsies with additional targeted cores according to results of functional prostate MRI detects high-risk prostate cancer in patients with previous negative biopsy and increased PSA - a pilot study.
    Arsov C; Quentin M; Rabenalt R; Antoch G; Albers P; Blondin D
    Anticancer Res; 2012 Mar; 32(3):1087-92. PubMed ID: 22399637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer.
    Porpiglia F; Russo F; Manfredi M; Mele F; Fiori C; Regge D
    Int Braz J Urol; 2015; 41(1):124-33. PubMed ID: 25928518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer.
    Numao N; Yoshida S; Komai Y; Ishii C; Kagawa M; Kijima T; Yokoyama M; Ishioka J; Matsuoka Y; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    J Urol; 2013 Aug; 190(2):502-8. PubMed ID: 23473904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiparametric MRI of the prostate with three functional techniques in patients with PSA elevation before initial TRUS-guided biopsy.
    Hauth E; Hohmuth H; Cozub-Poetica C; Bernand S; Beer M; Jaeger H
    Br J Radiol; 2015 Oct; 88(1054):20150422. PubMed ID: 26268144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.
    Pessoa RR; Viana PC; Mattedi RL; Guglielmetti GB; Cordeiro MD; Coelho RF; Nahas WC; Srougi M
    BJU Int; 2017 Apr; 119(4):535-542. PubMed ID: 27500389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MRI-directed cognitive fusion-guided biopsy of the anterior prostate tumors.
    Murphy IG; NiMhurchu E; Gibney RG; McMahon CJ
    Diagn Interv Radiol; 2017; 23(2):87-93. PubMed ID: 28074780
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening.
    Catalona WJ; Smith DS; Ratliff TL; Basler JW
    JAMA; 1993 Aug; 270(8):948-54. PubMed ID: 7688438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy.
    Jambor I; Kähkönen E; Taimen P; Merisaari H; Saunavaara J; Alanen K; Obsitnik B; Minn H; Lehotska V; Aronen HJ
    J Magn Reson Imaging; 2015 May; 41(5):1394-404. PubMed ID: 24956412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
    Thompson IM; Pauler Ankerst D; Chi C; Goodman PJ; Tangen CM; Lippman SM; Lucia MS; Parnes HL; Coltman CA
    J Clin Oncol; 2007 Jul; 25(21):3076-81. PubMed ID: 17634486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
    Hattangadi JA; Chen MH; D'Amico AV
    BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Value of Endorectal MRI in Romanian Men for High Risk of Prostate Cancer: MRI Findings Compared with Saturation Biopsy.
    Lebovici A; Sfrangeu SA; Caraiani C; Lucan C; Suciu M; Elec F; Iacob G; Buruian M;
    Chirurgia (Bucur); 2015; 110(3):262-7. PubMed ID: 26158736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.